+66%

est. 2Y upside i

HealthcareSeries A

Rank

#777

Sector

HealthTech

Est. Liquidity

~4Y

Data Quality

Data: Medium

Limbic offers moderate expected upside of 66% over 2 years, but the analysis is clouded by missing growth data and a stale valuation mark.

Last updated: July 19, 2026

Bull (20%)+175%

IF IPO window opens and category leadership recognized, exit multiple expands to 5x. Projected revenue of $34M yields $172M market cap (+175% after 20% dilution). High regulatory moat supports premium.

Base (55%)+65%

Exit multiple converges to public comp average of 3x. Revenue growth to $34M yields $103M market cap. 20% dilution reduces net upside to 65%.

Bear (25%)-18%

Multiple compresses to 1.5x due to competitive pressure and market downturns. Revenue growth may slow. Preference stack at 44% of valuation wipes out most returns; net loss of 18%.

Est. time to liquidity~4.0 years

Preference Stack Risk

severe

Funding Intensity

44%

Total funding of $21.8M vs $50.1M valuation implies 44% overhang, requiring a ~1.44x exit just to clear preferences before common stock sees value.

Dilution Risk

high

Given cash burn and lack of profitability, a Series B raise within 18-24 months is likely, diluting existing holders by 20-30%.

Secondary Liquidity

none

No secondary market activity detected; employee equity likely illiquid until exit.

Questions to Ask at the Interview

Strategic questions based on Limbic's data — designed to show you've done your homework.

  • 1

    How does Limbic plan to achieve profitability with its current Gross Margin of 75% and what is the path to $100M ARR?

  • 2

    With the recent Nature Medicine study showing AI outperforming therapists, how does Limbic intend to commercialize this advantage and manage potential regulatory pushback?

  • 3

    Given the $14M Series A in 2024 and 44% preference overhang, what is the expected timeline and terms for the next funding round, and how would that affect employee equity dilution?

Community

Valuation Sentiment

Our model estimates +66% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.